[Updated] EDBI emerges as SG biotech firm ImmunoScape's second-largest shareholder

[Updated] EDBI emerges as SG biotech firm ImmunoScape's second-largest shareholder

T-lymphocytes attack a migrating cancer cell. Visual from Medisix's website.

Edited by: Joymitra Rai

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter